Download PDF
Synlett 2003(2): 0166-0172
DOI: 10.1055/s-2003-36802
LETTER
© Georg Thieme Verlag Stuttgart · New York

Isothiazole Ring Formation with Substituted 2-Alkylthio-3-acyl-4-quinolinone Using O-(Mesitylenesulfonyl)hydroxylamine (MSH)

Jong Hee Choi, Eun Bok Choi, Chwang Siek Pak*
Korea Research Institute of Chemical Technology, Yusung-Ku Jang-Dong 100, Taejeon, 305-600, Korea
Fax: +82(42)8600307; e-Mail: cspak@krict.re.kr;
Further Information

Publication History

Received 9 December 2002
Publication Date:
22 January 2003 (online)

    Permissions and Reprints All articles of this category

Abstract

Isothiazole ring skeleton was formed by the treatment of substituted 2-alkylthio-3-acyl-4-quinolinone with O-(mesitylenesulfonyl)hydroxylamine(MSH). A mixture of alkyl transferred 3-methyl-9-alkyl-4,9-dihydroisothiazolo[5,4-b]quinolin-4-one as a major product and dealkylated 3-methyl-4,9-dihydroisothiazolo[5,4-b]quinolin-4-one as a minor product was obtained from unsubstituted 2-alkylthio-3-acyl-4-quinolinone in the presence of K2CO3. When 2 equivalents of MSH were used in the absence of K2CO3 only dealkylated product was obtained in quantitative yield.

Key words

imine - electrophilic addition - cyclizations - isothiazole - O-(mesitylenesulfonyl)hydroxyl amine

    References

  • 1 Komoriya K, Nagata I, Osada Y, and Kondo S. inventors; JP  90-183990.  ; Chem. Abstr. 1992, 117, 104253
  • 2 Romeo G. Bousquet E. Pappalardo MS. Ronsisvalle G. Oliveri S. Cammarata E. Farmaco  1988,  43:  457 
    Google Scholar
  • 3 Nagano N. Nakano K. Shibanuma T. Murakami Y. Hara R. J. Antibiot.  1987,  40:  173 
    Google Scholar
  • 4a Cutri CCC. Garozzo A. Siracusa MA. Castro A. Tempera G. Sarva MC. Guerrera F. Antiviral Res.  2002,  55:  357 
    Google Scholar
  • 4b Inglot AD. Machon Z. Wolna E. Wilimowski M. Prandota J. Arch. Immunol. Ther. Exp.  1973,  21:  891 
    Google Scholar
  • 5 Aebi J, Ackermann J, Dehmlow H, Maerki H.-P, and Morand O. inventors; PCT Int. Appl. WO  0236584.  ; Chem. Abstr. 2002, 136, 369719
  • 6a Kitagawa Y, Ishikawa K, Sawada H, Araki Y, Shigyo T, and Aszmann L. inventors; PCT Int. Appl. WO  0177090.  ; Chem. Abstr. 2001, 135, 318501
  • 6b Chemla P, Maetzke T, and Ertl P. inventors; PCT Int. Appl. WO  9932464.  ; Chem. Abstr. 1999, 131, 58832
  • 7a Heil M, Bretschneider T, Kleefeld G, Erdelen C, Turberg A, and Mencke N. inventors; Ger. Offen. DE  19736545.  ; Chem. Abstr. 1999, 130, 182458
  • 7b Cetusic J, and Rieder BJ. inventors; PCT Int. Appl. WO  0224691.  ; Chem. Abstr. 2002, 136, 279447
  • 7c Assmann L, Kitagawa Y, Ishikawa K, Sawada H, Araki Y, and Shigyo T. inventors; PCT Int. Appl, WO  0129014.  ; Chem. Abstr. 2001 134, 311204
  • 7d Andersch W, and Wachendorff-Neumann U. inventors; PCT Int. Appl. WO  0035286.  ; Chem. Abstr. 2000, 133, 39470
  • 8a Rahman LKA. Scrowston RM. J. Chem. Soc., Perkin Trans. 1.  1983,  2973 
    CrossrefGoogle Scholar
  • 8b Shimizu M. Kikumoto H. Konakahara T. Gama Y. Shibuya I. Heterocycles  1999,  15:  3005 
    CrossrefGoogle Scholar
  • 8c Chiyoda T. Iida K. Takatori K. Kajiwara M. Synlett  2000,  1427 
    CrossrefGoogle Scholar
  • 8d Zlotin SG. Kislitsin PG. Podgursky AV. Samet AV. Buchanan AG. Gakh AA. J. Org. Chem.  2000,  65:  8439 
    CrossrefGoogle Scholar
  • 9a Ikuo I. Kenner CR. J. Heterocycl. Chem.  1978,  15:  1527 
    Google Scholar
  • 9b Noris S. Chem. Pharm. Bull.  1980,  28:  761 
    Google Scholar
  • 9c Hull R. van den Broek PJ. Swain ML. J. Chem. Soc., Perkin Trans. 1  1975,  2271 
    Google Scholar
  • 9d Hull R. J. Chem. Soc., Perkin Trans. 1  1973,  2911 
    Google Scholar
  • 9e Daniel TWC. Claiborne AK. J. Heterocycl. Chem.  1990,  27:  1191 
    Google Scholar
  • 10a Cecchetti V. Fravolini A. Fringuelli R. Schiaffella F. J. Heterocycl. Chem.  1993,  30:  11431 
    Google Scholar
  • 10b Daniel TWC. Claiborne AK. J. Heterocycl. Chem.  1990,  27:  1191 
    Google Scholar
  • 11a Dieter RK. Chang HJ. J. Org. Chem.  1989,  54:  1088 
    Article in Thieme ConnectGoogle Scholar
  • 11b Laaman SM. Meth-Cohn O. Rees CW. Synthesis  1999,  757 
    Article in Thieme ConnectGoogle Scholar
  • 12a Iijima I. Rice KC. J. Heterocycl. Chem.  1978,  15:  1527 
    CrossrefGoogle Scholar
  • 12b Rahman LKA. Scrowston RM. J. Chem. Soc., Perkin Trans. 1.  1983,  2973 
    CrossrefGoogle Scholar
  • 13a Stumpf M. Hall H. Liebigs Ann. Chem.  1994,  1049 
    CrossrefGoogle Scholar
  • 13b Liu KC. Shin BJ. Hu MK. J. Heterocycl. Chem.  1987,  24:  1729 
    CrossrefGoogle Scholar
  • 13c Gunzenhauser S. Ball H. Helv. Chim. Acta  1985,  68:  56 
    CrossrefGoogle Scholar
  • 14a Anthony DM. Curtis RM. Christoper A. Ramsden Muhammad RR. Chem. Commun.  1999,  189 
    CrossrefGoogle Scholar
  • 14b William LM. Joyce ZZ. J. Org. Chem.  1990,  55:  5791 
    CrossrefGoogle Scholar
  • 14c Tamura Y. Sumoto K. Minamikawa J. Ikeda M. Tetrahedron Lett.  1972,  4137 
    CrossrefGoogle Scholar
  • 15a Haga N. Endo Y. Kataoka K. Yamaguchi K. Shudo K. J.Am. Chem. Soc.  1992,  114:  9795 
    CrossrefGoogle Scholar
  • 15b Kagechika H. Himi T. Namikawa K. Kawaki E. Hasimoto Y. Shudo K. J. Med. Chem.  1989,  32:  1098 
    CrossrefGoogle Scholar
  • 16a Keana JW. Heo GS. Gaughan GT. J. Org. Chem.  1985,  50:  2346 
    CrossrefGoogle Scholar
  • 16b Luh TY. Chow HF. Leung WY. Tam SW. Tetrahedron  1985,  41:  519 
    CrossrefGoogle Scholar
  • 17a Chenault J. Plisson C. Treillard P. Buisson Y. Edmont D. Synth. Commun.  2000,  30:  217 
    Google Scholar
  • 17b Aoki M, Kamata M, Ohtsuka T, Shimma N, and Yokose K. inventors; Eur. Pat. Appl.  259804.  ; Chem. Abstr. 1988, 109, 73478
  • 17c Wentland MP, and Balley DM. inventors; Eur. Pat.Appl.  90424.  ; Chem. Abstr. 1984, 100, 138969
  • 22 Guthrie JP. J. Am. Chem. Soc.  1974,  96:  3608 
    CrossrefGoogle Scholar
  • 23 Johnson CR. Corkins HG. J. Org. Chem.  1978,  43:  4136 
    CrossrefGoogle Scholar
  • 24a Segawa J. Kitano M. Kazuno K. Matsuoka M. Shirahase I. Ozaki M. Matsuda M. Tomii Y. Kise M. J. Med. Chem.  1992,  35:  4727 
    Google Scholar
  • 24b Matsuoka M. Segawa J. Makita Y. Ohmachi S. Kashima T. Nakamura KI. Hattori M. Kitano M. Kise M. J. Heterocycl. Chem.  1997,  34:  1773 
    Google Scholar
  • Entry 1:
  • 25a Bhat B. Bhaduri AP. Synthesis  1984,  673 
    CrossrefGoogle Scholar
  • 25b See also: Meth-Cohn O. Narine B. Tarnowski B. Tetrahedron Lett.  1979,  3111 
    CrossrefGoogle Scholar
  • 25c Entry 3: Eiden F. Rademacher G. Arch. Pharm. (Weinheim)  1983,  316:  34 
    CrossrefGoogle Scholar
  • 25d Entry 4: Smith JG. Dibble PW. Sandborn RE. J. Org. Chem.  1986,  51:  3762 
    CrossrefGoogle Scholar
  • 26a

    Electrophilic superdelocalizability was calculated with CacheWorkSystem version 3.2 program.
    Crossref
  • 26b Rogers KS. Cammarata A. J. Med. Chem.  1969,  12:  692 
    CrossrefGoogle Scholar
18

X-ray crystal structure analysis of 2a and 3f: Atomic coordinates, bond lengths [Å] and angles [deg], anisotropic displacement parameters, hydrogen coordinates, torsion angles [deg] have been deposited at Cambridge Crystallographic Data Centre 12, Union Road. Cambridge. CB2 1EZ, UK. Under deposition number CCDC 192773 for 2a,CCDC 192772 for 3f (Fax: +44(1223)336033, E-mail:deposit@ccdc.cam.ac.uk).

19

Representative Procedure: To a stirred solution of (1a) (300 mg, 1.28 mmol) in DMF (3 mL) was added K2CO3 (442 mg, 3.2 mmol). After Stirring for 30 min at r.t., MSH (304 mg, 1.41 mmol) was added in small portion during the period of 1 h. The mixture was stirred at r.t. for 4 h. The solvent was distilled off, and the residue was partitioned between EtOAc (500 mL) and H2O (80 mL). The organic layer was separated, washed with brine (50 mL), and dried with anhyd MgSO4. After filtering MgSO4, the solvent was evaporated under vacuum to give a mixture of crude products (267 mg) which was separated by column chromatography (hexanes:EtOAc = 3:1) to afford 3,9-dimethyl-9H-isothiazolo[5,4-b]quinolin-4-one (2a) (162 mg, 55%), 3-methyl-9H-isothiazolo[5,4-b]quinolin-4-one (3a) (83mg, 30%) and 2,4,6-trimethyl-benzenesufonic acid methyl ester (22 mg, 8%). (2a) Yield: 55%, Yellow solid,
Rf = 0.41 (CH2Cl2:MeOH = 30:1), mp 199-200 °C.
1H NMR (300 MHz, CDCl3): δ = 8.56-8.51 (m, 1 H),
7.79-7.70 (m, 1 H), 7.46-7.37 (m, 2 H), 3.84 (s, 3 H), 2.89 (s, 3 H).13C NMR (125 MHz, CDCl3): δ = 174.16, 170.24, 168.23, 140.61, 133.17, 127.51, 125.60, 123.29, 118.99, 113.69, 38.46, 21.09. MS: m/z = 230 (M+), 215, 197, 184, 169. HRMS (EI): calcd for C12H10N2O1S1: 230.0517.
Found: 230.0520. Anal. Calcd for C12H10N2O1S1: C, 62.59; H, 4.38; N, 12.16; S, 13.92. Found: C, 62.61; H, 4.41; N, 12.55; S, 13.83. (3a) Yield: 30%, Yellow solid, Rf = 0.08 (hexanes:EtOAC = 3:1), mp 342-344 °C. 1H NMR (200 MHz, DMSO-d 6): δ = 12.75 (s, 1 H), 8.25-8.22 (m, 1 H), 7.78-7.71 (m, 1 H), 7.53-7.49 (m, 1 H), 7.40-7.33 (m, 1 H), 2.72 (s, 3 H).13C NMR (125 MHz, DMSO-d 6): δ = 173.75, 165.97, 165.24, 140.07, 133.20, 125.93, 123.55, 122.93, 118.64, 117.60, 20.35. MS: m/z = 216 (M+), 199, 183, 170, 161. HRMS (EI): calcd for C11H8N2O1S1: 216.0360. Found: 216.0357. 2,4,6-Trimethyl-benzenesufonic Acid Methyl Ester: Yield: 8%, Yellow oil, Rf = 0.76 (hexanes:EtOAc = 3:1). 1H NMR (200 MHz, CDCl3): δ = 6.99 (s, 2 H), 3.70 (s, 3 H), 2.63 (s, 6 H), 2.32 (s, 3 H). MS: m/z = 214 (M+), 196, 182, 174, 165, 149.

20

1H NMR was run in Bruker AMX 500MHz in DMF-d 7. A mixture of MSH (22 mg) and 1a (12 mg) in 1mL of DMF-d 7 was used and the spectrum was run at an interval of 5 min up to 1 h. After 12th run 3 h, 1 d, 3 d interval spectrum was obtained.

21

In order to prepare GCMS sample for low boiling material, reaction was run under the standard condition. After 2 h, low boiling cut was collected using dry ice-acetone trap. The sample was analyzed in HP 5890 series II (GC) and HP5971 series MSD (mass detector). Conditions: capillary column DB-wax 30m × 0.25 mm (0.25 µm film thickness), ion source temperature 200 °C, injection temperature 250 °C: oven temperature 35 °C to ca. 240 °C programmed 10 °C/min, retention time: 2.08 min HCO2Me, 3.47 min MeOH.

27

Methylthio group of quinolinone 1a was removed by Raney nickel to provide 3-acyl-4-quinolinone (8) and acyl group of 1a was removed by treatment with trifluoro acetic acid as solvent to give 2-methylthio-4-quinolinone (9). Reaction of 8 or 9 with MSH did not proceed after overnight stirring under the same condition.